Myriad Genetics Inc (MYGN)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 1,027,600 1,081,300 1,085,100 1,110,500 1,146,500 1,149,100 1,187,200 1,169,300 1,198,700 1,212,000 1,210,200 1,255,400 1,320,700 1,335,900 1,360,300 1,336,900 1,418,800 1,444,500 1,404,600 1,446,700
Total stockholders’ equity US$ in thousands 701,100 731,700 740,500 760,000 783,200 683,400 735,200 835,200 885,800 916,600 947,400 950,100 967,800 968,600 902,500 875,200 879,900 909,300 918,200 967,200
Financial leverage ratio 1.47 1.48 1.47 1.46 1.46 1.68 1.61 1.40 1.35 1.32 1.28 1.32 1.36 1.38 1.51 1.53 1.61 1.59 1.53 1.50

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,027,600K ÷ $701,100K
= 1.47

The financial leverage ratio of Myriad Genetics Inc has been fluctuating over the reported periods, ranging from 1.28 to 1.68. A financial leverage ratio of 1 indicates an equal proportion of debt and equity in the company's capital structure.

From March 31, 2020, to September 30, 2021, the ratio showed a general increasing trend, peaking at 1.68 by September 30, 2021, indicating a higher level of financial leverage. This could imply that the company was relying more on debt to finance its operations during this period.

However, from September 30, 2021, to December 31, 2024, the ratio generally decreased, indicating a reduced reliance on debt financing and potentially a stronger equity position compared to previous periods.

Overall, the fluctuation in the financial leverage ratio of Myriad Genetics Inc suggests varying levels of debt and equity utilization in the company's capital structure over the reported periods. Monitoring changes in this ratio is important for assessing the company's risk profile and financial stability.


Peer comparison

Dec 31, 2024